Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a new platform revision label: v3.5.4 replaces the previous v3.5.3. This reflects a system update rather than a change to the study details or page content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label updated from v3.5.2 to v3.5.3, indicating a newer version of the study record or its accompanying documents.SummaryDifference0.0%

- Check41 days agoChange DetectedLocation labels were updated to standardize how certain site and region names are displayed (Chile and Turkey), and the page revision/version string was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a new publication entry: Win Ratio Analysis to Clarify Clinical Benefits: A Post Hoc Analysis of Phase 3 BOREAS and NOTUS. Chest. 2026 Mar 5: online ahead of print.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.